切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - COX - adrenoceptor - G-quadruplexes - Histone Deacetylases (HDACs)

56件产品中的 41-50

每页
清除全部
  1. Sodium Phenylbutyrate
    A4107 Sodium Phenylbutyrate
    中文名: 苯基丁酸钠
    Target: Histone Deacetylases (HDACs)
    Summary: 组蛋白去乙酰化酶抑制剂
      ≥6.3 mg/mL
      ≥27.65 mg/mL
  2. Scriptaid
    A4106 Scriptaid
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥13.1 mg/mL
      insoluble in H2O
  3. Resveratrol
    A4182 Resveratrol
     2 Citation
    中文名: 白藜芦醇
    Target: Sir2-like Family Deacetylases (Sirtuins)|COX|LOX|Adenylyl cyclase|Quinone reductase
    Summary: SIRT1激活剂
      ≥9.65 mg/mL
      insoluble in H2O
  4. ITF2357 (Givinostat)
    A4093 ITF2357 (Givinostat)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥23.8 mg/mL
      ≥2.9 mg/mL
  5. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: 多靶点HDAC抑制剂
      ≥21.7 mg/mL
      insoluble in H2O
  6. PCI-34051
    A4091 PCI-34051
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC8抑制剂
      ≥14.8 mg/mL
      insoluble in H2O
  7. JNJ-26481585
    A4090 JNJ-26481585
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥19.2 mg/mL
      insoluble in H2O
  8. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥19.8 mg/mL
      insoluble in H2O
  9. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    中文名: 伏立诺他
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC抑制剂
      ≥4.41 mg/mL
      insoluble in H2O
  10. Rocilinostat (ACY-1215)
    A4083 Rocilinostat (ACY-1215)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: 选择性的HDAC6抑制剂
      ≥21.675 mg/mL
      insoluble in H2O

56件产品中的 41-50

每页